Macrophage-biomimetic porous Se@SiO2 nanocomposites for dual modal immunotherapy against inflammatory osteolysis.
Cheng DingChuang YangTao ChengXingyan WangQiaojie WangRenke HeShang SangKechao ZhuDongdong XuJiaxing WangXijian LiuXianlong ZhangPublished in: Journal of nanobiotechnology (2021)
Our findings suggest that M-Se@SiO2 have an immunomodulatory role in LPS-induced inflammation and bone remodeling, which demonstrates that M-Se@SiO2 are a promising engineered nanoplatform for the treatment of osteolysis occurring after arthroplasty.